Radiofrequency Genicular Nerve Ablation for Refractory Knee Osteoarthritis
Yes, radiofrequency genicular nerve ablation is appropriate and should be offered to this patient who has failed conservative management including exercise, weight loss, NSAIDs, acetaminophen, and intra-articular corticosteroids.
Primary Recommendation
The 2022 AAOS guidelines 1 establish the treatment ladder for knee osteoarthritis but notably do not address radiofrequency ablation (RFA) as it was an emerging technology at guideline publication. However, the guidelines clearly support intra-articular corticosteroids as effective treatment with only 3-month duration of benefit, which this patient has already exhausted. When corticosteroid injections provide only temporary relief, genicular nerve RFA becomes the logical next step before considering surgical options.
Evidence Supporting RFA at This Stage
Short-term vs. Long-term Efficacy
The most recent 2026 meta-analysis 2 of sham-controlled RCTs (n=627 patients) demonstrates that genicular neurolysis, particularly conventional monopolar RFA, provides clinically meaningful pain reduction (MD -1.65 on pain scales at 12 weeks) and functional improvement (MD -11.37 on WOMAC function scores). Importantly, Trial Sequential Analysis confirmed these benefits are conclusive, not due to chance.
However, a competing 2026 meta-analysis 3 focusing specifically on image-guided techniques found that RFA provides significant pain relief only up to 3 months (SMD -1.65, P=0.040), with no sustained benefit at 6 or 12 months. This creates an important clinical nuance.
Comparative Effectiveness
The 2021 systematic review 4 of high-quality RCTs found RFA superior to:
- Intra-articular corticosteroids
- Hyaluronic acid injections
- NSAIDs
- Control/sham procedures
Most critically, the 2026 comparative study 5 showed that while IASI provides superior relief in the first week, RFA demonstrates progressively superior benefits from 1-6 months, with effect sizes increasing from small (SMD -0.398 at 1 month) to large (SMD -1.504 at 6 months). At 6 months, 22% of RFA patients reported complete pain relief versus only 4% with IASI.
Clinical Decision Algorithm
When to Proceed with RFA:
- Patient has failed a trial of intra-articular corticosteroid (as in this case) ✓
- Patient is not a surgical candidate or wishes to delay arthroplasty
- Pain significantly impacts quality of life despite conservative measures ✓
- Patient understands this provides 3-6 months of relief, not permanent cure
Expected Outcomes:
- Pain reduction: Expect meaningful improvement for 3-6 months
- Functional improvement: WOMAC scores improve significantly
- Repeat procedures: May be needed every 6-12 months as pain recurs
- Safety profile: No serious adverse events reported across all studies 2, 4, 6
Critical Advantages Over Continued Injections
RFA avoids the known risks of repeated corticosteroid injections, including accelerated cartilage loss and increased periprosthetic infection risk if the patient eventually requires arthroplasty 4. The AAOS guidelines 1 note corticosteroid benefits last only 3 months, requiring repeated injections that accumulate these risks.
Common Pitfalls to Avoid
Don't use pulsed RFA: Evidence supports conventional monopolar, cooled, or bipolar techniques—not pulsed 2
Ensure image guidance: All high-quality studies used fluoroscopy or ultrasound guidance 3
Target the correct nerves: Focus on superior medial, inferior medial, and superior lateral genicular nerves 6
Set realistic expectations: This is palliative, not disease-modifying. Pain will recur and repeat procedures are typical 7
Consider prognostic blocks: Though not universally required, diagnostic blocks may help predict treatment success 3
Addressing the Evidence Conflict
The apparent contradiction between studies showing 3-month versus 6-month efficacy [2 vs 3] likely reflects differences in RFA technique (conventional monopolar appears superior) and patient selection. The practical approach: offer RFA with the expectation of 3-6 months of meaningful relief, with the understanding that repeat procedures will likely be needed.
Why Not Continue Conservative Management?
The patient has exhausted the AAOS-recommended conservative ladder 1:
- ✓ Exercise and weight loss attempted
- ✓ NSAIDs and acetaminophen trialed
- ✓ Intra-articular corticosteroid completed
The next AAOS-endorsed step would be arthroplasty, but RFA provides an intermediate option that delays or potentially avoids surgery while maintaining quality of life 7, 8.